BioMarin Pharmaceutical
Brad Glasscock possesses extensive experience in regulatory affairs, currently serving as Senior Vice President and Head of Global Regulatory Affairs at BioMarin Pharmaceutical Inc. since February 2012. Prior roles at BioMarin include Group Vice President, Vice President, Executive Director, and Senior Director of Regulatory Affairs. Prior to BioMarin, Brad held the position of Director of Regulatory Affairs at Amgen from May 2005 to February 2012. Brad's career began at the FDA, where roles included Reviewer in the Office of Orphan Products Development and Regulatory Project Manager in the Center for Biologics Evaluation and Research. Brad holds a PharmD from the University of North Carolina at Chapel Hill.
BioMarin Pharmaceutical
42 followers
BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases.